Peripheral Arterial Disease Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Peripheral Arterial Disease Market is segmented By Treatment (Drug Therapy, Endovascular Therapy), By Disease (Peripheral Arterial Disease, Pulmonary Vascular Disease), By Patient (Adult, Elderly), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
Peripheral Arterial Disease Market Size
Market Size in USD
CAGR6.8%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 6.8% |
| Market Concentration | High |
| Major Players | Novartis, Bayer, Pfizer, Amgen, Sanof |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Peripheral Arterial Disease Market Analysis
The peripheral arterial disease market is estimated to be valued at USD 4.8 Bn in 2024 and is expected to reach USD 7.61 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.8% from 2024 to 2031. The increasing prevalence of diabetes, obesity, and hypertension are major factors driving the growth of the peripheral arterial disease market.